Evidence map›Paper›PMID 34564781›Full record

ReviewEJNMMI radiopharmacy and chemistry2021

Closing the gap between

Javier Ajenjo, Gianluca Destro, Bart Cornelissen, Véronique Gouverneur

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in EJNMMI radiopharmacy and chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 57 citations in OpenAlex.

  1. A Ni-Mediated Cross-Coupling Approach to DeuteratedJournal of the American Chemical Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Trifluoromethylation of alkyl electrophiles withScience (New York, N.Y.) · 2025
    Article
  6. Article
  7. Article
  8. Organic letters · 2024
    Article
  9. Article
  10. Article
  11. Photoredox Nucleophilic (Radio)fluorination of Alkoxyamines.Journal of the American Chemical Society · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Fluorinated carbohydrates forChemical Society reviews · 2023
    Review
  16. Review
  17. Next Generation Copper Mediators for the Efficient Production ofChemistry (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  18. Recent Advances inPharmaceutics · 2022
    Review
  19. [Nature · 2022
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Javier Ajenjo *Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
Gianluca Destro *Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
Bart CornelissenMedical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
Véronique GouverneurChemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, OX1 3TA, UK. veronique.gouverneur@chem.ox.ac.uk.ORCID http://orcid.org/0000-0001-8638-5308
University of Oxford · GB

Funding

Cancer Research UK 23970Medical Research Council MR/S008209/1
6 · The paper itself

Abstract

Positron emission tomography (PET) has become an invaluable tool for drug discovery and diagnosis. The positron-emitting radionuclide fluorine-18 is frequently used in PET radiopharmaceuticals due to its advantageous characteristics; hence, methods streamlining access to

Indexed as

FluorideFluorinePositron emission tomographyRadiochemistryRadiofluorination

Identifiers

PMID34564781
PMCPMC8464544
OpenAlexW3203612906

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.